selenious acid has been researched along with carboplatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobra, K; Hjerpe, A; Mundt, F; Nilsonne, G; Souri, P; Szulkin, A; Wasik, AM | 1 |
| Caffrey, PB; Frenkel, GD | 1 |
| Buckley, B; Caffrey, PB; Frenkel, GD; Gibbon, DG; Gounder, M; Hellmann, M; Kane, MP; Kumaran, MN; Nieves-Neira, W; Rodriguez-Rodriguez, L; Shih, W; Song, M; Vaidya, A | 1 |
1 trial(s) available for selenious acid and carboplatin
| Article | Year |
|---|---|
Phase I trial of selenium plus chemotherapy in gynecologic cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Line, Tumor; Chemotherapy-Induced Febrile Neutropenia; DNA-Binding Proteins; Down-Regulation; Female; Gene Expression; Glutathione Peroxidase; Humans; Infections; Lung Diseases; Maximum Tolerated Dose; Middle Aged; Nervous System Diseases; Ovarian Neoplasms; Paclitaxel; Response Evaluation Criteria in Solid Tumors; RNA-Binding Proteins; Selenious Acid; Selenium; Selenoprotein P | 2018 |
2 other study(ies) available for selenious acid and carboplatin
| Article | Year |
|---|---|
Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy.
Topics: Amino Acid Transport System y+; Antineoplastic Agents; Biomarkers, Tumor; Boronic Acids; Bortezomib; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Multidrug Resistance-Associated Proteins; Pemetrexed; Pyrazines; Selenious Acid | 2013 |
Prevention of carboplatin-induced resistance in human ovarian tumor xenografts by selenite.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Mice; Mice, Nude; Selenious Acid; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |